PRISM PHARMACEUTICALS, INC. – Trademark Portfolio

Entity Type: 03

PRISM PHARMACEUTICALS, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEXTERONE. The owner is based in FLORENCE, KY.

7300 TURFWAY ROAD

SUITE 300

FLORENCE, KY 41042

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PRISM PHARMACEUTICALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does PRISM PHARMACEUTICALS, INC. have?

PRISM PHARMACEUTICALS, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.

What trademark classes does PRISM PHARMACEUTICALS, INC. file in?

PRISM PHARMACEUTICALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are PRISM PHARMACEUTICALS, INC.'s most well-known trademarks?

PRISM PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as NEXTERONE. These are among 1 currently registered trademark in the portfolio.

What is PRISM PHARMACEUTICALS, INC.'s trademark registration success rate?

PRISM PHARMACEUTICALS, INC. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.